Apr 11 minElection of Executives on the Third Annual (2023FY) General Shareholder Meeting We would like to inform you that the following officers were elected at our company's third annual (2023FY) general shareholder meeting...
Jan 131 minNotice of Patent License Agreement for a Novel CAR T-Cell Therapy Targeting GD2 AntigenJanuary 13, 2024 T Celll Nouveau Inc. Notice of Patent License Agreement for a Novel CAR T-Cell Therapy Targeting GD2 Antigen T Cell...
Mar 8, 20231 minHomepage updatedT Cell Nouveau Inc. has updated corporate website reflecting changes in Executive team, Scientific Advisory Board, Strategy and Pipeline.
